Roxana Schillaci
8PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 15, 2023
Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.Santiago Madera, Franco Izzo, María F Chervo
|Apr 13, 2023
Emerging Targeted Therapies for HER2-Positive Breast Cancer.María Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro
|Mar 08, 2023
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression.Sofia Bruni, Florencia L Mauro, Cecilia J Proietti
|May 09, 2022
Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.Santiago Madera, Franco Izzo, María F Chervo
|Feb 05, 2021
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.María Florencia Mercogliano, Sofía Bruni, Florencia Mauro
|Jul 08, 2020
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis.Santiago Madera, María F Chervo, Violeta A Chiauzzi
Pageof 2
Frequent Collaborators
5 joint publications
Cecilia J Proietti
4 joint publications
Patricia V Elizalde
3 joint publications
Sofía Bruni
3 joint publications
Rosalía I Cordo Russo
3 joint publications
Santiago Madera
2 joint publications
María Florencia Mercogliano
1 joint publications
Florencia Sabbione
1 joint publications
Paula M Berguer
1 joint publications
Analía S Trevani
1 joint publications
Mara De Martino
